Inaugural IMPPC Symposium on Genomics, Epigenomics & Predictive Medicine of Cancer

11 December 2009
Hotel Colon, Av Catedral, Barcelona

Genomics, Epigenomics & Predictive Medicine of Cancer

Angel Pellicer (Chair) » New York University, New York
OVERVIEW
09.20 George Klein » Karolinska Institute, Stockholm
Cancer proneness and host resistance – an overview

CANCER GENETICS & SUSCEPTIBILITY

10.00 Jun Yokota » National Cancer Center Research Institute, Tokyo
Inter-individual differences in lung adenocarcinoma susceptibility defined by combined genotypes of two genes, HLA-DQA1 & TERT.
10.40 Robert Hofstra » University Medical Center, Groningen
Lynch syndrome: old genes, new mutations.
11.20 Coffee Break
11.40 Richard Hamelin » INSERM, Paris
"Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis”. A tribute 16 years after.
12.20 Raquel Seruca » IPATIMUP, Porto
MAPkinase mutations in MSI gastrointestinal tumours.
13.00 Manuel Serrano » Spanish Natl Cancer Res Center (CNIO), Madrid
Tumour suppressors at the interface between cancer and aging.
13.40 Lunch Break

CANCER EPIGENETICS & EPIDEMIOLOGY

15.30 Manuel Perucho » IMPPC, Barcelona
Genetics, epigenetics, and the link between aging and gastrointestinal cancer.
16.10 Victor Corces » Emory University, Atlanta
Nuclear organization and gene expression.
16.50 Coffee Break
17.10 Maria Blasco » Spanish National Cancer Research Center (CNIO), Madrid
Role of telomeres & telomerase in cancer and aging.
17.50 Kristiina Vuori » Burnham Institute for Medical Research (BIMR), La Jolla
From basic cancer research to drug discovery.
18.30 Xavier Bosch » Institut Català d’Oncologia (ICO), Barcelona
Transition to prevention: the history of a cancer vaccine.
 

Top

Generalitat de Catalunya

Unió Europea

CSIC

Universitat Autònoma de Barcelona

Ajuntament de Badalona

Institut Català de la Salut

Germans Trias i Pujol Hospital

Fundació Institut d'investigació en Ciències de la Salut Germans Trias i Pujol